Lam, Sean Shao Wei http://orcid.org/0000-0002-0898-5858
Fang, Andrew Hao Sen
Koh, Mariko Siyue
Shantakumar, Sumitra
Yeo, See-Hwee
Matchar, David Bruce
Ong, Marcus Eng Hock
Poon, Ken Mei Ting
Huang, Liming
Harikrishan, Sudha
Milea, Dominique
Burke, Des
Webb, Dave
Ragavendran, Narayanan
Tan, Ngiap Chuan
Loo, Chian Min
Funding for this research was provided by:
GlaxoSmithKline
Article History
Received: 20 April 2022
Accepted: 25 November 2022
First Online: 9 January 2023
Declarations
:
: Ethics board approval was obtained as part of the SDG-CARE collaboration, prior to developing the SCDM (SingHealth Centralized Institutional Review Board Ref No. 2017/2950). Informed consent has been waived by SingHealth Centralized Institutional Review Board Ref No. 2017/2950.
: Not applicable as the research does not involve any individual person’s data.
: This study was funded by GlaxoSmithKline plc (study number PRJ3057). SS, SHY, DM, DB and DW are full-time employees of GSK. SS, DM, DB and DW also own stocks in GlaxoSmithKline plc. SWSL, HSAF, MSK, DBM, EHMO, MTKP, HL, SH, NR, NCT and CML are full-time employees of SingHealth Duke NUS Academic Medical Centre (including SingHealth Polyclinics, Singapore General Hospital, Singapore Health Services Research Centre and Integrated Health Information Systems) and Duke-NUS Medical School. They report no conflicts of interest.